CCOC(=O)C1SC2(C(F)(F)C(F)F)CC1(O)c1c(c(OC)c3occc3c1OC)O2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?